AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
LONDON, GREATER LONDON, UNITED KINGDOM, November 13, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!
The nuclear medicine diagnostics market has grown rapidly, projected to rise from $6.57 billion in 2023 to $7.34 billion in 2024 at a CAGR of 11.7%, spurred by imaging technology, chronic disease trends, oncology applications, and diagnostic precision.
How Big Is the Global Nuclear Medicine Diagnostics Market Expected to Grow, and What Is Its Annual Growth Rate?
The nuclear medicine diagnostics market is expected to reach $11.31 billion in 2028 at a CAGR of 11.4%, driven by neurology, precision medicine, theranostics, and disease eradication. Trends include decentralized radiopharmacy, neurology applications, R&D collaboration, and safety focus.
Uncover In-Depth Analysis of the Global Nuclear Medicine Diagnostics Market by Accessing a Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp
What Is Driving the Growth of the Nuclear Medicine Diagnostics Market?
The rising incidence of cancer is anticipated to drive growth in the nuclear medicine diagnostics market. Cancer, a group of diseases marked by the uncontrolled spread of abnormal cells forming tumors, relies on nuclear medicine diagnostics for detection, staging, and monitoring. This technology uses radioactive substances to produce detailed images of organ and tissue functions, aiding in precise cancer assessment.
Pre-book the report for a swift delivery:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report
Which Leading Companies Are Driving The Growth Of The Nuclear Medicine Diagnostics Market Share?
Major companies operating in the market report are Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC.
What Are The Key Trends Driving The Growth Of The Nuclear Medicine Diagnostics Market Size?
Leading companies in the nuclear medicine diagnostics industry are prioritizing the launch of advanced solutions, including innovative medical technologies, to strengthen their competitive position. These advanced technologies aim to improve patient outcomes, elevate care standards, and support overall health improvements.
How Is the Global Nuclear Medicine Diagnostics Market Segmented?
1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Institutes
North America: The Leading Region in the Nuclear Medicine Diagnostics Market
North America was the largest region in the nuclear medicine diagnostics global market in 2023. The regions covered in the market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is the Nuclear Medicine Diagnostics Market?
Nuclear medicine involves using radioactive substances for diagnostic purposes or to treat diseases by targeting and removing damaged organs and tissues. It uses radioactive tracers to measure or visualize the function of organs.
The Nuclear Medicine Diagnostics Global Market Report 2024 from The Business Research Company includes the following key information:
• Market size data for both historical and future periods
• Analysis of both macro and microeconomic factors that have impacted the market over the past five years
• Regional market analysis covering Asia-Pacific, China, Western Europe, Eastern Europe, North America, the USA, South America, and the Middle East and Africa
• Country-specific market analysis for Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.
Overview of the Global Nuclear Medicine Diagnostics Market Report: Trends, Opportunities, Strategies, and More
The Nuclear Medicine Diagnostics Global Market Report 2024 from The Business Research Company is an extensive resource that delivers insights into nuclear medicine diagnostics market size, nuclear medicine diagnostics market drivers and trends, nuclear medicine diagnostics global market major players, nuclear medicine diagnostics competitors' revenues, nuclear medicine diagnostics global market positioning, and nuclear medicine diagnostics market growth across geographies. This report provides valuable in-depth insights into potential opportunities and strategies. Companies can utilize the information presented to target segments with the greatest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Nuclear Medicine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Nuclear Fusion Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nuclear-fusion-global-market-report
Spent Nuclear Fuel Waste Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/spent-nuclear-fuel-waste-management-global-market-report
What Services Does The Business Research Company Offer?
The Business Research Company has published more than 15,000 reports spanning 27 industries and over 60 regions. Our research is supported by 1.5 million datasets, thorough secondary research, and unique insights gained from interviews with industry experts. We offer ongoing and customized research services, featuring a variety of specialized packages designed to meet your specific needs, such as Market Entry Research, Competitor Tracking, Supplier & Distributor Packages, and many others.
Our flagship product, the Global Market Model, serves as a leading market intelligence platform that provides comprehensive and updated forecasts to facilitate informed decision-making.
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
